In a report released today, Eric Hagen from BTIG maintained a Buy rating on Ellington Financial (EFC – Research Report), with a price target of ...

Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a ...

BTIG raised the firm’s price target on Organogenesis (ORGO) to $7 from $6 and keeps a Buy rating on the shares after its Q4 results. The firm ...

Flywire (NASDAQ:FLYW – Get Free Report) was downgraded by equities research analysts at BTIG Research from a “buy” rating to ...

Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...